CTS Eventim AG & Co. KGaA / Preliminary announcement on the disclosure of financial statements 20.08.2014 15:55 Announcement according to articles 37v, 37w, 37x ff. WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- CTS Eventim AG & Co. KGaA hereby announces that the following financial reports shall be disclosed : Report: Financial report of the group (half-year/Q2) Date of disclosure / German: August 27, 2014 Date of disclosure / English: August 27, 2014 German: http://www.eventim.de/obj/media/DE-eventim/re...wnload/201 4/6_Monatsbericht_2014.pdf English: http://www.eventim.de/obj/media/en/relations/...014/6_Mont h_Report_2014.pdf 20.08.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: CTS Eventim AG & Co. KGaA Dingolfinger Str. 6 81673 München Germany Internet: www.eventim.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-AFR: CTS Eventim AG & Co. KGaA: Announcement according
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Ipsen's Kayfanda® Receives EU Approval for Alagille Syndrome Treatment
Kayfanda® Receives Approval for Treatment in the EU Ipsen has made a noteworthy advancement in pediatric healthcare with the recent authorization of Kayfanda® (odevixibat) in the European Union (EU). This innovative treatment specifically addresses cholestatic pruritus, a painful symptom linked to Alagille Syndrome, a rare liver disorder that affects children. This...
Continue Reading
Discover the Remarkable Returns of Vulcan Materials Stock
Unveiling Vulcan Materials Company Stock Performance Vulcan Materials Co. (NYSE: VMC) has been a noteworthy performer in the stock market over the past 15 years, surpassing market expectations with a commendable annual return of 15.1%. This stock has consistently outperformed the market, achieving an admirable 2.86% advantage annually. With a current market capitalization...
Continue Reading
AeroPress Launches Premium Coffee Press with Elegant Design
AeroPress introduced its Premium coffee press back in 2024, and you can bet the market was watching closely. With a retail price of $149.95, this isn’t just another brewing tool; it’s a statement piece designed for those who take their morning ritual seriously. Traders buzzed about how this could impact sales in a saturated market where every new gadget fights for...
Continue Reading
Investigation Update: Walgreens Boots Alliance Class Action Lawsuit
Overview of the Walgreens Boots Alliance Class Action Levi & Korsinsky, LLP has raised awareness among investors regarding a class action securities lawsuit involving Walgreens Boots Alliance, Inc. This company, known for its extensive pharmaceutical and retail operations, is currently facing legal challenges that could significantly impact its investors. Class Definition...
Continue Reading
Savillex Strengthens Market Position with New Acquisition
Savillex Acquires Optimum Processing to Enhance Offerings Thompson Street Capital Partners (TSCP) is proud to announce that its portfolio company, Savillex, has completed the acquisition of Optimum Processing, Inc. This strategic move is expected to elevate Savillex's position in the marketplace by combining its innovative fluid handling solutions with Optimum...
Continue Reading